[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"$fmnNUIN2ypBNHhtW4zNak-BHyAruQPouCozzEd49GmQc":3},{"item":4,"storyV2":72},{"slug":5,"type":6,"track":7,"season":8,"date":9,"featured":10,"teamName":11,"institution":13,"projectTitle":15,"summary":18,"body":20,"tags":24,"aiTags":27,"wetlabTags":30,"awards":33,"logoUrl":36,"materials":37,"gallery":38,"editorial":47,"cover":70},"neopep","image","T1","2026","2026-01-01",false,{"zh":12,"en":12},"NeoPep",{"zh":14,"en":14},"兰州大学萃英学院",{"zh":16,"en":17},"AI 启寻 —— 靶向 CB1 的镇痛肽设计","AI Peptide Quest — CB1-targeted analgesic peptide design",{"zh":19,"en":19},"用生成模型和虚拟筛选寻找 CB1 候选多肽，并开展细胞与动物模型验证",{"zh":21,"en":23},[22],"NeoPep 以 CB1 受体为靶点，使用生成模型和虚拟筛选寻找候选多肽，再通过细胞实验检查受体活性，并计划在动物疼痛模型中评估候选表现。",[22],{"zh":25,"en":26},[],[],{"zh":28,"en":29},[],[],{"zh":31,"en":32},[],[],{"zh":34,"en":35},[],[],"\u002Fapi\u002Fteam-showcase\u002Fneopep\u002Fmedia\u002Fce7624fff1d2ea297ebd20293",{},[39],{"imageUrl":40,"alt":41,"title":43,"description":45,"position":46},"\u002Fapi\u002Fteam-showcase\u002Fneopep\u002Fmedia\u002Fc4b1e91553769e97e4f9a221f",{"zh":42,"en":42},"三名成员对照实验记录，核对候选肽制备和检测结果，再确定下一轮验证顺序。",{"zh":44,"en":44},"实验结果集中复核",{"zh":42,"en":42},"center center",{"proposition":48,"listEvidence":49},{"zh":19,"en":19},[50,55,60,65],{"value":51,"label":53},{"zh":52,"en":52},"6 人",{"zh":54,"en":54},"成员人数",{"value":56,"label":58},{"zh":57,"en":57},"杨瑜妍",{"zh":59,"en":59},"队长",{"value":61,"label":63},{"zh":62,"en":62},"CB1 受体",{"zh":64,"en":64},"项目靶点",{"value":66,"label":68},{"zh":67,"en":67},"细胞 + 动物模型",{"zh":69,"en":69},"验证方式",{"tone":71,"heroImageUrl":40,"heroImagePosition":46},"bio",{"version":73,"publicSlug":5,"identity":74,"proposition":78,"lead":79,"listEvidence":80,"narrativeTendency":93,"hero":94,"presentation":99,"chapters":110},2,{"teamName":75,"projectTitle":76,"institution":77,"track":7},{"zh":12,"en":12},{"zh":16,"en":17},{"zh":14,"en":14},{"zh":19,"en":19},{"zh":22,"en":22},[81,84,87,90],{"value":82,"label":83},{"zh":52,"en":52},{"zh":54,"en":54},{"value":85,"label":86},{"zh":57,"en":57},{"zh":59,"en":59},{"value":88,"label":89},{"zh":62,"en":62},{"zh":64,"en":64},{"value":91,"label":92},{"zh":67,"en":67},{"zh":69,"en":69},"evidence-led",{"role":95,"title":96,"caption":97,"alt":98,"position":46,"imageUrl":40},"TEAM",{"zh":44,"en":44},{"zh":42,"en":42},{"zh":42,"en":42},{"template":100,"variant":101,"logo":102,"openingMedia":109},"documentary-profile","rich",{"role":103,"title":104,"caption":106,"alt":108,"position":46,"imageUrl":36},"LOGO",{"zh":105,"en":105},"队徽 NEOPEP",{"zh":107,"en":107},"字母 N 上升成一支箭，周围环绕着一串珠链状的肽。",{"zh":107,"en":107},[],[111,120,153,187,218],{"id":112,"eyebrow":113,"title":115,"body":117,"theme":119,"type":119},"project-background",{"zh":114,"en":114},"项目背景",{"zh":116,"en":116},"换一个靶点",{"zh":118,"en":118},"NeoPep 以 CB1 受体为靶点，使用生成模型和虚拟筛选寻找候选多肽，再通过细胞实验检查受体活性，并计划在动物疼痛模型中评估镇痛效果和其他反应。项目目标是探索区别于阿片类药物的候选路径。","problem",{"id":121,"eyebrow":122,"title":124,"body":126,"theme":128,"type":129,"facts":130,"image":145},"research-context",{"zh":123,"en":123},"研究路径",{"zh":125,"en":125},"先造一百万条",{"zh":127,"en":127},"筛选的前提是有东西可筛。因为天然肽库的覆盖是历史给定的，而生成模型可以按靶点的需求去「造」—— 它探索的是自然界没走过、但化学上合理的那部分空间。代价是这一百万条里绝大多数都不成立。所以真正的工作量在后面：虚拟筛选。","source","source-context",[131,135,140],{"label":132,"value":134},{"zh":133,"en":133},"靶点",{"zh":62,"en":62},{"label":136,"value":138},{"zh":137,"en":137},"肽库规模",{"zh":139,"en":139},"百万级",{"label":141,"value":143},{"zh":142,"en":142},"验证",{"zh":144,"en":144},"细胞 + 动物疼痛模型",{"role":146,"title":147,"caption":149,"alt":151,"position":46,"imageUrl":152},"WET_LAB",{"zh":148,"en":148},"候选肽合成操作",{"zh":150,"en":150},"队员在实验台前处理反应体系，记录候选肽由计算序列进入实物合成的环节。",{"zh":150,"en":150},"\u002Fapi\u002Fteam-showcase\u002Fneopep\u002Fmedia\u002Fcb843fae483b9410d8e5b5782",{"id":154,"eyebrow":155,"title":157,"theme":159,"type":160,"semantics":161,"steps":162},"project-process",{"zh":156,"en":156},"项目过程",{"zh":158,"en":158},"项目推进与验证路径","process","process-flow","hybrid",[163,172,179],{"order":164,"phase":165,"title":167,"body":169,"status":171},1,{"zh":166,"en":166},"阶段 1",{"zh":168,"en":168},"合成出来，测一遍",{"zh":170,"en":170},"筛完之后是这个项目里最实在的一步 —— 固相合成。多肽固相合成是把氨基酸一个一个接到树脂上，逐步延长。这一步意味着从此不再是数据：候选肽变成了几管真实的白色粉末，可以称重，可以进质谱，可以做实验。体外验证：通过细胞实验验证它们是否真的能激活 CB1 受体。这一步是整条链路的第一个硬门槛。模型觉得像激动剂的分子，到细胞上未必真的有功能。","described",{"order":73,"phase":173,"title":175,"body":177,"status":171},{"zh":174,"en":174},"阶段 2",{"zh":176,"en":176},"再到动物模型",{"zh":178,"en":178},"能激活受体，还不等于能镇痛。所以队伍的最后一步是：在动物疼痛模型上评估其镇痛效果。从「体外能结合」到「体内有效」，中间隔着吸收、分布、代谢、能不能过血脑屏障、以及在整体动物身上是否会出现别的反应 —— 每一环都可能让一个漂亮的体外数据落空。",{"order":180,"phase":181,"title":183,"body":185,"status":171},3,{"zh":182,"en":182},"阶段 3",{"zh":184,"en":184},"数据回流",{"zh":186,"en":186},"闭环的最后一环，队伍写得很明确：实验数据会回流给 AI，用于优化下一轮设计，形成「计算预测—实验验证—迭代优化」的完整闭环。这在肽类药物设计里尤其要紧。生成模型初始时对「什么样的肽能激活 CB1」只有间接的知识；而每一轮真实的活性数据，都是在把这个分布往正确的方向拧。希望以此为基础，为开发更安全的新型镇痛药物探索一条可行的新路径。是「探索一条可行的路径」，不是「开发出一种新药」。",{"id":188,"eyebrow":189,"title":191,"theme":193,"type":194,"items":195},"project-figure",{"zh":190,"en":190},"项目证据",{"zh":192,"en":192},"项目图表与方法记录","evidence","figures",[196,204,211],{"role":197,"title":198,"caption":200,"alt":202,"position":46,"imageUrl":203},"RESULT",{"zh":199,"en":199},"候选肽色谱检测",{"zh":201,"en":201},"色谱峰用于检查合成候选肽的纯化状态，为后续细胞验证确认样品质量。",{"zh":201,"en":201},"\u002Fapi\u002Fteam-showcase\u002Fneopep\u002Fmedia\u002Fc6c90abfbf23de6425ebc734b",{"role":146,"title":205,"caption":207,"alt":209,"position":46,"imageUrl":210},{"zh":206,"en":206},"候选肽纯化",{"zh":208,"en":208},"队员操作液相系统分离合成样品，把计算筛出的序列转化为可进入活性检测的候选肽。",{"zh":208,"en":208},"\u002Fapi\u002Fteam-showcase\u002Fneopep\u002Fmedia\u002Fc8424a7b1e7e380ea3fd419dd",{"role":197,"title":212,"caption":214,"alt":216,"position":46,"imageUrl":217},{"zh":213,"en":213},"纯化结果复核",{"zh":215,"en":215},"色谱界面显示样品分离峰，团队据此检查候选肽是否满足后续实验要求。",{"zh":215,"en":215},"\u002Fapi\u002Fteam-showcase\u002Fneopep\u002Fmedia\u002Fc46f061f3f3eaa25a9ed11d39",{"id":219,"eyebrow":220,"title":222,"theme":224,"type":225,"highlight":226,"full":235},"team-interview",{"zh":221,"en":221},"队伍专访",{"zh":223,"en":223},"听 NeoPep 讲述项目路径","media","interview",{"version":227,"title":228,"description":230,"durationSeconds":232,"videoUrl":233,"posterUrl":234},"highlight",{"zh":229,"en":229},"项目精华",{"zh":231,"en":231},"项目核心内容与队伍表达的精华剪辑。",188.666666,"\u002Fapi\u002Fteam-showcase\u002Fneopep\u002Fmedia\u002Fcd92b95f827da98d6ee38d749","\u002Fapi\u002Fteam-showcase\u002Fneopep\u002Fmedia\u002Fc4602966dd8bcd8faca091fa0",{"version":236,"title":237,"description":239,"durationSeconds":241,"videoUrl":242,"posterUrl":234},"full",{"zh":238,"en":238},"完整访谈",{"zh":240,"en":240},"按采访问题完整收录的队伍访谈。",382.5,"\u002Fapi\u002Fteam-showcase\u002Fneopep\u002Fmedia\u002Fc4316d9f51c0301c643c94bca"]